Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614666 · ClinicalTrials.gov registry record · Phase 1
Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment
A Phase 1 study, sponsored by University of Arizona.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00614666 is a Phase 1 study that was terminated before completion, run by University of Arizona. The registered enrollment target is 6 participants.
The verdict
NCT00614666, a Phase 1 study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if nikkomycin Z is safe when administered at different dose levels for 14 days. The study will also determine blood levels and urinary excretion of nikkomycin Z in relation to dose administered. Patients with mild forms of Valley Fever pneumonia will be eligible to participate and will be allocated to receive treatment with nikkomycin Z (various doses) or a placebo. A secondary goal of this study is to evaluate the effectiveness and dose response of nikkomycin Z in an exploratory analysis.
Interventions
- DRUG Placebo
- DRUG nikkomycin Z
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00614666
The ClinicalTrials.gov registry entry for NCT00614666 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00614666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00614666 about?
NCT00614666 is a clinical study titled "Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment". The purpose of this study is to determine if nikkomycin Z is safe when administered at different dose levels for 14 days. The study will also determine blood levels and urinary excretion of nikkomycin Z in relation to dose administered. Patients with mild forms of Valley Fever pneumonia will be elig...
What is the current status of trial NCT00614666?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2007-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00614666?
The interventions under investigation include: Placebo (DRUG), nikkomycin Z (DRUG).
Who is sponsoring clinical trial NCT00614666?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.